DUBLIN, Jan. 26, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/bxdn7d/in_vitro_cancer) has announced the addition of the "In Vitro Cancer Diagnostic Markets Global Market Size, Strategies and Forecasts 2016 to 2020 " report to their offering.
The Diagnostic, Monitoring and Screening Test opportunities of the In Vitro Cancer market are explored in this comprehensive report. The report identifies the current and future drivers, challenges and opportunities facing this market, offering readers an unrivaled understanding of the key topics all market participants should be aware of.
The in vitro cancer diagnostic market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.
Use independent research that makes you the expert. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it.
Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers. What is the size of the huge screening opportunity?
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Liquid Biopsy Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
10. Potential Market Opportunity Sizes
I. United States Medicare System: January 2015 Clinical Laboratory Fees Schedule - National Limit and Midpoint
II. FDA Approved Human Genetic Tests
III. FDA Approved Pharmacogenomics Tests
For more information visit http://www.researchandmarkets.com/research/bxdn7d/in_vitro_cancer
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets